U.S. Supreme Court
Jun. 25, 2011
High Court Blocks Suits Against Generic Drugmakers
The U.S. Supreme Court set a different standard for generic drug manufacturers on Thursday than it did for brand-name pharmaceuticals two years ago in terms of compliance with state laws for warning consumers about harmful side effects.
Daily Journal Staff Writer
The U.S. Supreme Court set a different standard for generic drug manufacturers on Thursday than it did for brand-name pharmaceutical companies two years ago in terms of compliance with state laws for warning consumers about harmful side effects.
The court said in a 5-4 opinion written by Justice Clarence Thomas that it would've been impossible for generic drugmakers Activis Inc. and Pliva Inc. to...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In